XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development $ 21,172 $ 16,538 $ 44,135 $ 33,983
General and administrative 3,849 4,072 8,137 8,062
Total operating expenses 25,021 20,610 52,272 42,045
Loss from operations (25,021) (20,610) (52,272) (42,045)
Other income (expense):        
Interest income 968 106 1,768 113
Other income (expense), net 54 (1,397) 1,233 (777)
Total other income (expense) 1,022 (1,291) 3,001 (664)
Net loss $ (23,999) $ (21,901) $ (49,271) $ (42,709)
Net loss per share, basic (in USD per share) $ (0.54) $ (0.72) $ (1.12) $ (1.49)
Net loss per share, diluted (in USD per share) $ (0.54) $ (0.72) $ (1.12) $ (1.49)
Weighted-average common shares outstanding, basic (in shares) 44,432,955 30,248,767 44,036,352 28,686,910
Weighted-average common shares outstanding, diluted (in shares) 44,432,955 30,248,767 44,036,352 28,686,910